Calian Group (TSE:CGY) Stock Price Expected to Rise, Desjardins Analyst Says

Calian Group (TSE:CGY) had its price target hoisted by research analysts at Desjardins from C$59.00 to C$66.00 in a report issued on Thursday,BayStreet.CA reports. The firm currently has a “buy” rating on the stock. Desjardins’ price target would suggest a potential upside of 21.97% from the stock’s previous close.

CGY has been the subject of several other reports. CIBC lifted their target price on Calian Group from C$59.00 to C$62.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 29th. Royal Bank Of Canada lifted their price objective on shares of Calian Group from C$58.00 to C$66.00 and gave the company an “outperform” rating in a report on Thursday. Ventum Financial boosted their price objective on shares of Calian Group from C$58.00 to C$62.00 and gave the company a “buy” rating in a research report on Thursday. Finally, Canaccord Genuity Group raised their target price on shares of Calian Group from C$60.00 to C$63.00 and gave the stock a “buy” rating in a research report on Thursday. Five analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus price target of C$63.80.

Calian Group Stock Up 2.5%

TSE CGY opened at C$54.11 on Thursday. The company has a quick ratio of 1.20, a current ratio of 1.29 and a debt-to-equity ratio of 39.54. Calian Group has a 52 week low of C$37.70 and a 52 week high of C$54.35. The firm has a market capitalization of C$613.88 million, a price-to-earnings ratio of -901.83, a PEG ratio of 2.50 and a beta of 0.43. The company has a fifty day moving average of C$50.48 and a two-hundred day moving average of C$48.76.

Calian Group Company Profile

Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management.